六核苷酸重复序列修饰X连锁肌张力障碍帕金森综合征的表现度
该研究在355例XDP患者中分析SVA插入内六核苷酸重复数与起病年龄、临床表现、严重度及认知功能的关系,发现重复数越低起病越早、TAF1表达越低且病情越重,重复数在种系传递中不稳定并存在脑内体细胞嵌合。
要点
- 六核苷酸重复数越低,XDP起病年龄越早且病情越重。
- 起病时表现为肌张力障碍还是帕金森综合征与起病年龄直接相关而非重复数。
- 该重复序列在种系传递中不稳定并可在脑内呈现体细胞嵌合。
核心结论
- SVA插入内的六核苷酸重复是XDP疾病表现度的遗传修饰因素。
- 重复数依赖的TAF1抑制及随后的TAF1 mRNA水平差异可能通过脑内体细胞变异被增强而影响神经表型。
研究设计与样本
- 对355例XDP患者进行六核苷酸重复基因分型,并将重复数与起病年龄(n=295)、首发临床表现(n=294)、肌张力障碍起病部位(n=238)、疾病严重度(n=28)及认知功能(n=15)进行相关分析。
- 采用两名患者死后脑组织进行分离分析和Southern印迹以研究重复不稳定性,并检测31例XDP患者血RNA中TAF1相对表达。
主要发现
- 重复数与起病年龄及TAF1表达呈显著负相关,与疾病严重度和认知功能障碍呈正相关。
- 起病时表现为肌张力障碍还是帕金森综合征与起病年龄(而非重复数)直接相关。
- 口/舌肌张力障碍患者的重复数低于眼睑痉挛患者。
- 重复数在种系传递中不稳定,总体倾向长度增加,并在脑内呈现体细胞嵌合。
临床怎么用
- 六核苷酸重复数可作为XDP起病年龄、严重度和认知功能的遗传修饰指标。
- 起病时运动表型(肌张力障碍或帕金森综合征)的判断应结合起病年龄而非仅依据重复数。
局限性
- 疾病严重度(n=28)和认知功能(n=15)分析样本量较小。
- TAF1表达分析仅基于31例患者血液RNA,脑内体细胞嵌合仅在两例死后脑组织中观察。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: X-linked dystonia parkinsonism (XDP) is a neurodegenerative movement disorder caused by a single mutation: SINE-VNTR-Alu (SVA) retrotransposon insertion in TAF1. Recently, a (CCCTCT)n repeat within the SVA insertion has been reported as an age-at-onset (AAO) modifier in XDP. Here we investigate the role of this hexanucleotide repeat in modifying expressivity of XDP. METHODS: We genotyped the hexanucleotide repeat in 355 XDP patients and correlated the repeat number (RN) with AAO (n = 295), initial clinical manifestation (n = 294), site of dystonia onset (n = 238), disease severity (n = 28), and cognitive function (n = 15). Furthermore, we investigated i) repeat instability by segregation analysis and Southern blotting using postmortem brain samples from two affected individuals and ii) relative TAF1 expression in blood RNA from 31 XDP patients. RESULTS: RN showed significant inverse correlations with AAO and with TAF1 expression and a positive correlation with disease severity and cognitive dysfunction. Importantly, AAO (and not RN) was directly associated with whether dystonia or parkinsonism will manifest at onset. RN was lower in patients affected by mouth/tongue dystonia compared with blepharospasm. RN was unstable across germline transmissions with an overall tendency to increase in length and exhibited somatic mosaicism in brain. INTERPRETATION: The hexanucleotide repeat within the SVA insertion acts as a genetic modifier of disease expressivity in XDP. RN-dependent TAF1 repression and subsequent differences in TAF1 mRNA levels in patients may be potentiated in the brain through somatic variability leading to the neurological phenotype. ANN NEUROL 2019;85:812-822.
引用
- Westenberger A, Reyes CJ, Saranza G, et al. A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism. Ann Neurol. 2019. PMID: 30973967. doi:10.1002/ana.25488
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。